Jinjian Sun1,2, Haocheng Lu1, Wenying Liang1, Guizhen Zhao1, Lu Ren3, Die Hu1,2, Ziyi Chang1,2, Yuhao Liu1,2, Minerva T Garcia-Barrio1, Jifeng Zhang1, Y Eugene Chen1, Yanbo Fan1,3,4. 1. Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan Medical Center, Ann Arbor (J.S., H.L., W.L., G.Z., D.H., Z.C., Y.L., M.T.G.-B., J.Z., Y.E.C., Y.F.). 2. Department of Cardiovascular Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China (J.S., D.H., Z.C., Y.L.). 3. Department of Cancer Biology (L.R., Y.F.), University of Cincinnati College of Medicine, OH. 4. Division of Cardiovascular Health and Disease, Department of Internal Medicine (Y.F.), University of Cincinnati College of Medicine, OH.
Abstract
OBJECTIVE: Vascular endothelial cells (ECs) play a critical role in maintaining vascular homeostasis. Aberrant EC metabolism leads to vascular dysfunction and metabolic diseases. TFEB (transcription factor EB), a master regulator of lysosome biogenesis and autophagy, has protective effects on vascular inflammation and atherosclerosis. However, the role of endothelial TFEB in metabolism remains to be explored. In this study, we sought to investigate the role of endothelial TFEB in glucose metabolism and underlying molecular mechanisms. Approach and Results: To determine whether endothelial TFEB is critical for glucose metabolism in vivo, we utilized EC-selective TFEB knockout and EC-selective TFEB transgenic mice fed a high-fat diet. EC-selective TFEB knockout mice exhibited significantly impaired glucose tolerance compared with control mice. Consistently, EC-selective TFEB transgenic mice showed improved glucose tolerance. In primary human ECs, small interfering RNA-mediated TFEB knockdown blunts Akt (AKT serine/threonine kinase) signaling. Adenovirus-mediated overexpression of TFEB consistently activates Akt and significantly increases glucose uptake in ECs. Mechanistically, TFEB upregulates IRS1 and IRS2 (insulin receptor substrate 1 and 2). TFEB increases IRS2 transcription measured by reporter gene and chromatin immunoprecipitation assays. Furthermore, we found that TFEB increases IRS1 protein via downregulation of microRNAs (miR-335, miR-495, and miR-548o). In vivo, Akt signaling in the skeletal muscle and adipose tissue was significantly impaired in EC-selective TFEB knockout mice and consistently improved in EC-selective TFEB transgenic mice on high-fat diet. CONCLUSIONS: Our data revealed a critical role of TFEB in endothelial metabolism and suggest that TFEB constitutes a potential molecular target for the treatment of vascular and metabolic diseases.
OBJECTIVE: Vascular endothelial cells (ECs) play a critical role in maintaining vascular homeostasis. Aberrant EC metabolism leads to vascular dysfunction and metabolic diseases. TFEB (transcription factor EB), a master regulator of lysosome biogenesis and autophagy, has protective effects on vascular inflammation and atherosclerosis. However, the role of endothelial TFEB in metabolism remains to be explored. In this study, we sought to investigate the role of endothelial TFEB in glucose metabolism and underlying molecular mechanisms. Approach and Results: To determine whether endothelial TFEB is critical for glucose metabolism in vivo, we utilized EC-selective TFEB knockout and EC-selective TFEB transgenic mice fed a high-fat diet. EC-selective TFEB knockout mice exhibited significantly impaired glucose tolerance compared with control mice. Consistently, EC-selective TFEB transgenic mice showed improved glucose tolerance. In primary human ECs, small interfering RNA-mediated TFEB knockdown blunts Akt (AKT serine/threonine kinase) signaling. Adenovirus-mediated overexpression of TFEB consistently activates Akt and significantly increases glucose uptake in ECs. Mechanistically, TFEB upregulates IRS1 and IRS2 (insulin receptor substrate 1 and 2). TFEB increases IRS2 transcription measured by reporter gene and chromatin immunoprecipitation assays. Furthermore, we found that TFEB increases IRS1 protein via downregulation of microRNAs (miR-335, miR-495, and miR-548o). In vivo, Akt signaling in the skeletal muscle and adipose tissue was significantly impaired in EC-selective TFEB knockout mice and consistently improved in EC-selective TFEB transgenic mice on high-fat diet. CONCLUSIONS: Our data revealed a critical role of TFEB in endothelial metabolism and suggest that TFEB constitutes a potential molecular target for the treatment of vascular and metabolic diseases.
Authors: Jose L Viñas; Dylan Burger; Joseph Zimpelmann; Randa Haneef; William Knoll; Pearl Campbell; Alex Gutsol; Anthony Carter; David S Allan; Kevin D Burns Journal: Kidney Int Date: 2016-09-17 Impact factor: 10.612
Authors: Marco Sardiello; Michela Palmieri; Alberto di Ronza; Diego Luis Medina; Marta Valenza; Vincenzo Alessandro Gennarino; Chiara Di Malta; Francesca Donaudy; Valerio Embrione; Roman S Polishchuk; Sandro Banfi; Giancarlo Parenti; Elena Cattaneo; Andrea Ballabio Journal: Science Date: 2009-06-25 Impact factor: 47.728
Authors: Kevin Wei; Stephanie M Piecewicz; Lisa M McGinnis; Cullen M Taniguchi; Stanley J Wiegand; Keith Anderson; Carol W-M Chan; Kimberly X Mulligan; David Kuo; Jenny Yuan; Mario Vallon; Lori Morton; Etienne Lefai; M Celeste Simon; Jacquelyn J Maher; Gilles Mithieux; Fabienne Rajas; Justin Annes; Owen P McGuinness; Gavin Thurston; Amato J Giaccia; Calvin J Kuo Journal: Nat Med Date: 2013-09-15 Impact factor: 53.440